Elena Pérez‐Ceballos

Fludarabine, Cyclophosphamide, and Mitoxantrone as Initial Therapy of Chronic Lymphocytic Leukemia: High Response Rate and Disease Eradication

Francesc Bosch, Ana Ferrer, Neus Villamor et al. · Clinical Cancer Research · 2008 · 120 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis

Javier Corral, David Hernández‐Espinosa, Jose Manual Soria et al. · Blood · 2007 · 103 citations

Medicine, Genetics, Hematology +15

Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy

Lourdes Martín‐Martín, Júlia Almeida, Helena Pomares et al. · Oncotarget · 2016 · 89 citations · Full text

Medicine, Hematology, Oncology +15

Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non‐Hodgkin’s lymphoma patients at high risk of central nervous system disease in the rituximab era

Juan‐Manuel Sancho, Alberto Órfão, Sandra Quijano et al. · European Journal Of Haematology · 2010 · 57 citations

Medicine, Oncology, Pathology +13

A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis

Javier Corral, Rocío Gónzález‐Conejero, José Manuel Soria et al. · Blood · 2006 · 56 citations · Full text

Medicine, Genetics, Molecular Genetics +14